Finally, reprogramming to an immature state enables AML cells to evade differentiation therapy,193 and melanoma cells exposed to treatment downregulate SOX10, hence limiting SOX10-mediated differentiation in support of chemoresistance.197. This evidence concerns the gene SOX10 and acute myeloid leukemia.